This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CareFusion Provides Update On Form 10-K, 10-Q Filings

SAN DIEGO, Dec. 19, 2012 /PRNewswire/ -- CareFusion Corporation (NYSE: CFN) said today it has completed the majority of the analysis to be used in determining the impact of an accounting modification on its financial statements. Based on the analysis to date, the company has not identified information that would lead it to conclude that its previously issued financial statements should no longer be relied upon. CareFusion is in the process of completing its analysis and the documentation required to finalize its fiscal 2012 independent audit.

As previously disclosed, CareFusion is modifying the manner in which it applies lease accounting principles to sales-type leases in its Pyxis ® medication and supply dispensing product lines, delaying the filing of its Form 10-K for fiscal 2012 and Form 10-Q for the quarter ended Sept. 30.

The matter does not affect CareFusion customers or the underlying fundamentals and cash flows of the company or its Pyxis business.

"While restatement will continue to be a possibility until our analysis is complete, we have not identified any information that would lead us to conclude that our previously issued financial statements should no longer be relied upon or that the financial guidance we provided for fiscal 2013 should be changed," said James F. Hinrichs, chief financial officer. "If at any time we determine a material misstatement exists, we would file a Form 8-K shortly thereafter announcing a restatement is required. At this point, our goal is to become current in all filings by our next deadline on Feb. 11, 2013. Clearly, we are working diligently to file sooner, if possible."

On Nov. 8, the company said it would provide an update on the matter in approximately one month. As a result, CareFusion will host a webcast and conference call today at 5 a.m. PST ( 8 a.m. EST).  

To access the call, visit the Investors page at www.carefusion.com. Log on at least 15 minutes before the call begins to register and download or install any necessary audio software. Investors and other interested parties may also access the call by dialing (800) 510-0146 within the U.S. or (617) 614-3449 from outside the U.S., using the access code 64995265. A replay of the conference call will be available from 7 a.m. PST ( 10 a.m. EST) on Dec. 19 through 11:59 p.m. PST on Dec. 26 ( 2:59 a.m. EST on Dec. 27) and can be accessed by dialing (888) 286-8010 in the U.S. or (617) 801-6888 internationally and using the access code 67989805.

About CareFusionCareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris ® infusion pumps, Pyxis ® automated dispensing and patient identification systems, AVEA ®, AirLife and LTV ® series ventilation and respiratory products, ChloraPrep ® skin prep products, MedMined ® services for data mining surveillance, V. Mueller ® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at http://www.carefusion.com/.

Cautions Concerning Forward-looking Statements

The CareFusion news release and the information contained herein present "forward-looking statements" addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments, including statements regarding the modified application of lease accounting principles to the company's sales-type leases; the analysis regarding the impact of the accounting modification; the potential impact of the accounting modification on the company's reported financial results and financial guidance; and the timing for filing the company's Form 10-K for fiscal 2012 and Form 10-Q for the quarter ended Sept. 30. CareFusion intends forward-looking terminology such as "believes," "expects," "may," "will," "should," "anticipates," "plans," or similar expressions to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause the company's actual results to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that additional information may arise during the course of the company's lease accounting review that may require the company to make additional adjustments; the time and effort required to complete the company's analysis and the review by the company's independent auditors; and the time and effort required to make any adjustments to the company's financial reports, if required, as well as other risks described more fully in Item 1A in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2011, which are expressly incorporated herein by reference, and other factors as may periodically be described in the company's filings with the SEC. The CareFusion news release and the information contained herein reflect management's views as of Dec. 19, 2012. Except to the limited extent required by applicable law, CareFusion undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE CareFusion Corp.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,550.69 -47.51 -0.27%
S&P 500 2,093.32 -4.72 -0.22%
NASDAQ 5,105.5460 -9.8360 -0.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs